Opportunity overview
As a first step towards evaluating the use of RNA vaccines for livestock, the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) collaborated to carry out a proof-of-principle study. The success of this work has led to the continued evaluation by CVIM of RNA-based vaccines for livestock. To enable this, CVIM is developing an in-house RNA platform. To facilitate the continued evaluation of RNA-based vaccines for livestock CVIM needs to develop the capacity to produce formulated mRNA vaccine candidates at a suitable scale to carry out in vivo immunogenicity studies. This platform requires stringent in-process quality control (QC). A dynamic light scattering (DLS) machine is required to check the integrity of encapsidated RNA particles prior to its use in such studies.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Malvern Panalytical Limited
- Published award value
- Value not stated
- Awarded
- Not supplied
- Contract signed
- 28 Apr 2025
- Award ID
- 1
- Status
- active
- Location
- Malvern, UKG12, WR14 1XZ, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract details notice on Find a TenderOpen source ↗